Clinical Trial Update: Methylphenidate as Treatment Option of Fatigue in Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating methylphenidate as a treatment option for fatigue in people with multiple sclerosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue
• Multiple Sclerosis

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Medical University of Vienna | Conditions: Multiple Sclerosis, Fatigue | Phase 2 | Status: UNKNOWN